SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001504167-16-000010
Filing Date
2016-12-13
Accepted
2016-12-13 16:14:50
Documents
3
Period of Report
2016-12-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bpmx-20161208x8k.htm 8-K 42546
2 EX-99.1 bpmx-20161208ex991280327.htm EX-99.1 300416
3 GRAPHIC bpmx20161208ex991280327001.jpg GRAPHIC 7098
  Complete submission text file 0001504167-16-000010.txt   354088
Mailing Address 1098 HAMILTON COURT MENLO PARK CA 94025
Business Address 1098 HAMILTON COURT MENLO PARK CA 94025 650-889-5020
BioPharmX Corp (Filer) CIK: 0001504167 (see all company filings)

IRS No.: 593843182 | State of Incorp.: DE | Fiscal Year End: 0131
Type: 8-K | Act: 34 | File No.: 001-37411 | Film No.: 162049050
SIC: 2834 Pharmaceutical Preparations